ストックスクリーナーアプリを入手
13.96
4.97%
-0.73
プレマーケット:
13.96
前日終値:
$14.69
開ける：
$14.55
24時間の取引高:
368.58K
Relative Volume:
1.04
時価総額：
$282.07M
収益：
$80.54M
当期純損益:
$-62.79M
株価収益率:
-4.4696
EPS:
-3.1233
ネットキャッシュフロー:
$20.76M
1週間 パフォーマンス:
-11.14%
1か月 パフォーマンス:
+7.06%
6か月 パフォーマンス:
-19.45%
1年 パフォーマンス:
-54.70%
1日の値動き範囲:
$13.71
$14.87
1週間の範囲:
$13.71
$17.32
52週間の値動き範囲:
$11.09
$34.01
Simulations Plus Inc Stock (SLP) Company Profile
名前
Simulations Plus Inc
セクター
電話
661-723-7723
住所
800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA
Compare SLP vs VEEV, BTSG, TEM, HQY, DOCS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLP
Simulations Plus Inc
|
13.96 | 296.82M | 80.54M | -62.79M | 20.76M | -3.1233 |
VEEV
Veeva Systems Inc
|
159.42 | 26.00B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
55.50 | 10.68B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.95 | 8.70B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
80.46 | 6.90B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
26.45 | 4.85B | 637.78M | 239.40M | 307.21M | 1.1909 |
Simulations Plus Inc Stock (SLP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-18 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-09-30 | 開始されました | TD Cowen | Hold |
| 2025-07-15 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-11-15 | 開始されました | Stephens | Overweight |
| 2024-07-29 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2024-07-16 | 開始されました | JMP Securities | Mkt Perform |
| 2024-06-28 | 開始されました | William Blair | Outperform |
| 2023-05-09 | 開始されました | BTIG Research | Buy |
| 2021-10-26 | アップグレード | Craig Hallum | Hold → Buy |
| 2021-01-12 | ダウングレード | Craig Hallum | Buy → Hold |
| 2020-10-16 | 開始されました | Raymond James | Outperform |
| 2020-09-08 | 開始されました | Oppenheimer | Outperform |
| 2020-01-06 | 開始されました | Craig Hallum | Buy |
すべてを表示
Simulations Plus Inc (SLP) 最新ニュース
TradingKey - TradingKey
[144] Simulations Plus, Inc. SEC Filing - Stock Titan
Nicholas Company Inc. Buys 78,854 Shares of Simulations Plus, Inc. $SLP - MarketBeat
NVIDIA Pushes AI Into Drug Development With Simulations Plus Collaboration - Yahoo Finance
Simulations Plus unveils method for QST model integration with microphysiological data in liver risk analysis - Traders Union
Simulations Plus collaborates with NVIDIA during AI drug modeling push - MSN
Simulations Plus, Inc. (SLP): Investor Outlook With A 47% Potential Upside - DirectorsTalk Interviews
SLP Stock Price, Quote & Chart | SIMULATIONS PLUS INC (NASDAQ:SLP) - ChartMill
Simulations Plus (SLP) Partners with NVIDIA for Advanced Drug De - GuruFocus
Simulations Plus teams with NVIDIA on drug modeling - Engineering.com
Simulations Plus (NASDAQ:SLP) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - HPCwire
Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push - Benzinga
Simulations Plus partners with Nvidia on AI drug development By Investing.com - Investing.com India
Simulations Plus partners with Nvidia on AI drug development - Investing.com
Simulations Plus stock surges 28% on NVIDIA collaboration - Investing.com
Simulations Plus And NVIDIA Collaborate To Scale GPU-Accelerated, AI-Assisted Modeling Workflows - marketscreener.com
Insider Sell Alert: DiBella John Anthony II Sells Shares of Simu - GuruFocus
[Form 4] Simulations Plus, Inc. Insider Trading Activity - Stock Titan
Simulations Plus (SLP) insiders sell 15,000 shares in planned trade - Stock Titan
Do options traders know something about Simulations Plus stock we don't? - MSN
(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Do Options Traders Know Something About Simulations Plus Stock We Don't? - Zacks Investment Research
Simulations Plus (SLP) director receives 2,117-share equity grant as compensation - Stock Titan
Director Sharlene Evans receives 2,117 SLP shares in equity grant - Stock Titan
Director at Simulations Plus (SLP) receives 2,117-share stock grant - Stock Titan
Simulations Plus (SLP) director awarded 2,117 shares as equity compensation - Stock Titan
AI in Predictive Toxicology Research Report 2026 Featuring - GlobeNewswire
AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance UK
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Latest SLP NewsSimulations Plus Announces Quarterly Cash Di... - Stock Titan
Simulations Plus Q2 2026 earnings preview - MSN
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm
(SLP) Risk Channels and Responsive Allocation - Stock Traders Daily
Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations - MSN
SLP Simulations Plus posts strong Q1 2026 results, shares rise over four percent on double digit EPS and revenue gains.Debt/Equity - Xã Thanh Hà
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Nigeria
Simulations Plus (SLP) Partners with FDA and Lonza for Drug Perf - GuruFocus
Simulations Plus enters funded research collaboration with Lonza, FDA - TipRanks
Simulations Plus partners with Lonza and FDA on drug formulation research By Investing.com - Investing.com South Africa
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products - Business Wire
SLP SEC FilingsSimulations Plus Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Simulations Plus (SLP) Completes Successful Spring School Traini - GuruFocus
What Happened to Simulations Plus (SLP) Stock Today (Wavering) 2026-04-20Continuation Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School - 01net
Simulations Plus Inc (SLP) 財務データ
収益
当期純利益
現金流量
EPS
2.05%
2.56%
大文字化:
|
ボリューム (24 時間):